FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

WESTON PRESIDIO V LP

2. Date of Event Requiring Statement (MM/DD/YYYY)
1/21/2010 

3. Issuer Name and Ticker or Trading Symbol

Cellu Tissue Holdings, Inc. [CLU]

(Last)        (First)        (Middle)

PIER 1, BAY 2

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            ___ X ___ 10% Owner
_____ Officer (give title below)          _____ Other (specify below)

(Street)

SAN FRANCISCO, CA 94111       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4) 		2. Amount of Securities Beneficially Owned
(Instr. 4) 		3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) 		4. Nature of Indirect Beneficial Ownership
(Instr. 5)

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4) 		2. Date Exercisable and Expiration Date
(MM/DD/YYYY) 		3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) 		4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) 		6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Series A Preferred Stock   (1)   (1)   (1) Common Stock   12014548     (1) D    
Series B Preferred Stock   (2)   (2)   (2) Common Stock   2660832     (2) D    
Common Stock   (3)   (3)   (3) Common Stock   1672     (3) D    

Explanation of Responses:
( 1)  Represents shares of Series A Preferred Stock of Cellu Parent Corporation which are convertible into Issuer Common Stock upon the closing of the Issuer's initial public offering. Cellu Parent Corporation will be merged into Issuer on the terms disclosed in the Issuer's Form S-1 Registration Statement dated January 21, 2010.
( 2)  Represents shares of Series B Preferred Stock of Cellu Parent Corporation which are convertible into Issuer Common Stock upon the closing of the Issuer's initial public offering. Cellu Parent Corporation will be merged into Issuer on the terms disclosed in the Issuer's Form S-1 Registration Statement dated January 21, 2010.
( 3)  Represents shares of Common Stock of Cellu Parent Corporation which are convertible into Issuer Common Stock upon the closing of the Issuer's initial public offering. Cellu Parent Corporation will be merged into Issuer on the terms disclosed in the Issuer's Form S-1 Registration Statement dated January 21, 2010.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
WESTON PRESIDIO V LP
PIER 1, BAY 2
SAN FRANCISCO, CA 94111
X

Weston Presidio Management V, LLC
PIER 1, BAY 2
SAN FRANCISCO, CA 94111
X


Signatures
/s/ Therese A. Mrozek, COO of Genl Ptr of LP 1/21/2010
** Signature of Reporting Person Date

/s/ Therese A. Mrozek, COO of LLC 1/21/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Canada Life (NYSE:CLU)
Graphique Historique de l'Action
De Jan 2025 à Fév 2025 Plus de graphiques de la Bourse Canada Life
Canada Life (NYSE:CLU)
Graphique Historique de l'Action
De Fév 2024 à Fév 2025 Plus de graphiques de la Bourse Canada Life